---
title: "US FDA approves Novo's insulin injection for type 2 diabetes"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/280702235.md"
description: "March 26 (Reuters) - The U.S. Food and Drug Administration (FDA) has approved Novo Nordisk's insulin injection, Awiqli, to improve blood sugar levels in adults living with type 2 diabetes, the company said on Thursday. (Reporting by Carlos Méndez in Mexico City; Editing by Rashmi Aich)"
datetime: "2026-03-26T23:52:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280702235.md)
  - [en](https://longbridge.com/en/news/280702235.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280702235.md)
---

# US FDA approves Novo's insulin injection for type 2 diabetes

March 26 (Reuters) - The U.S. Food and Drug Administration (FDA) has approved Novo Nordisk's insulin injection, Awiqli, to improve blood sugar levels in adults living with type 2 diabetes, the company said on Thursday. (Reporting by Carlos Méndez in Mexico City; Editing by Rashmi Aich)

### Related Stocks

- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [NVO.US](https://longbridge.com/en/quote/NVO.US.md)

## Related News & Research

- [Wegovy Liver Data Broadens Semaglutide Story For Novo Nordisk Investors](https://longbridge.com/en/news/286980981.md)
- [Key facts: Novo Nordisk early −21.6% 64w; Rexall delivery Canada](https://longbridge.com/en/news/286343869.md)
- [CDSCO asks states, UTs to monitor surrogate promotion for GLP-1 drugs](https://longbridge.com/en/news/286925029.md)
- [Novo Nordisk data shows oral semaglutide delivers significant weight loss in phase 3 trial](https://longbridge.com/en/news/286239982.md)
- [Novo Nordisk Highlights New Wegovy Pill Data](https://longbridge.com/en/news/286293294.md)